
Researchers at the Wellcome Sanger Institute and Open Targets have been able to identify thousands of genes which play a …

Merrimack Pharmaceuticals has taken the decision to terminate development of its antibody-directed nanotherapeutic cancer therapy MM-310 in the treatment of …

Top officials at the Memorial Sloan Kettering Cancer Center repeatedly violated policies on financial conflicts of interest, according to details …

At the 2019 American Association for Cancer Research (AACR) Annual Meeting in Atlanta, Clovis Oncology took the opportunity to present …

Britain’s cost effectiveness body, the National Institute for Health and Care Excellence (NICE), has recommended Eli Lilly’s Verzenio (abemaciclib) in …

British biotech Artios Pharma have appointed experienced oncologist Dr Ian Smith, as the company’s new Chief Medical Officer (CMO). Dr …

Britain’s cost effectiveness body has recommended Takeda’s Adcetris (brentuximab vedotin) for adult patients with CD-30 positive advanced cutaneous T-cell lymphoma …

Pfizer and Merck KGaA have chosen to discontinue the Phase 3 JAVELIN trial looking into avelumab in combination with chemotherapy …

Death rates from breast cancer are falling faster in Britain than in any of the other six most populous countries …

Radiation immediately following surgery in children with the third most common form of paediatric brain tumour, ependymoma, can triple survival, …

While immunotherapies continue to be the darling of the industry, new, innovative and sometimes seemingly fantastical research is emerging that …

Edinburgh-based drug discovery firm AdoRx therapeutics has signed a deal with US healthcare conglomerate Johnson & Johnson to develop novel …

Almost half of all children with cancer are going untreated and undiagnosed, according to research published in Lancet Oncology. While …

The Justice Department and US Securities and Exchanges Commission are investigation healthcare giant Johnson & Johnson over allegations that Johnson’s …

Smoking may limit the body’s ability to fight melanoma, according to a study published in the journal Cancer Research. The …